SEC Comment Letter 0000000000-25-001326 to Ocugen, Inc. (OCGN) (CIK 0001372299) (OCGN)
Ocugen, Inc. (OCGN) (CIK 0001372299)
Date: Feb. 6, 2025 · CIK: 0001372299 · Accession: 0000000000-25-001326
AI Filing Summary & Sentiment
File numbers found in text: 333-284629
Letter
February 6, 2025 Shankar Musunuri Chief Executive Officer Ocugen, Inc. 12 Great Valley Parkway Malvern, PA 19355 Re:Ocugen, Inc. Registration Statement on Form S-3 Filed January 31, 2025 File No. 333-284629 Dear Shankar Musunuri: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Jennifer Porter, Esq.
Show Raw Text
February 6, 2025
Shankar Musunuri
Chief Executive Officer
Ocugen, Inc.
12 Great Valley Parkway
Malvern, PA 19355
Re:Ocugen, Inc.
Registration Statement on Form S-3
Filed January 31, 2025
File No. 333-284629
Dear Shankar Musunuri:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Jennifer Porter, Esq.